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Synchrotron activation radiotherapy: Effects of dose-rate and energy spectra to
tantalum oxide nanoparticles selective tumour cell radiosensitization
enhancement
Abstract
Synchrotron radiation is unique in its ability to deliver dose at high dose rates using kiloelectronvolt
photons. We are investigating the use of Tantalum pentoxide (Ta2O5) nano-structured particles (NSPs)
that are to date unexplored in synchrotron radiation fields as they have high atomic number (Z=73) are
biocompatible and are therefore potential radio sensitizers. We exposed cell culture flasks containing 9L
gliosarcoma tumour cells or Madin-Darby Canine Kidney (MDCK) non-tumour cells to the NSPs and
treated the cells using a broad synchrotron beam (140 keV median energy; average dose rate of 50 Gy/s)
at the Australian Synchrotron. We compare the results with those from similar cells treated using a
conventional 150 kVp orthovoltage field (dose rate of 0.0127 Gy/s). The results reveal that the high doserate synchrotron irradiation is more effective at killing the 9L cells relative to the MDCK cells than the
orthovoltage irradiation. On the other hand, the NSPs are more effective at radiosensitizing the 9L cells
compared to the MDCK cells in the orthovoltage radiation field, which is due to the NSP energy
dependence in the kilovoltage energy range. Both the dose rate and energy spectrum need to be
considered in future studies with synchrotron activation radiotherapy (SART).
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Abstract. Synchrotron radiation is unique in its ability to deliver dose at high dose rates using
kiloelectronvolt photons. We are investigating the use of Tantalum pentoxide (Ta2O5) nanostructured particles (NSPs) that are to date unexplored in synchrotron radiation fields as they
have high atomic number (Z=73) are biocompatible and are therefore potential radio sensitizers.
We exposed cell culture flasks containing 9L gliosarcoma tumour cells or Madin-Darby Canine
Kidney (MDCK) non-tumour cells to the NSPs and treated the cells using a broad synchrotron
beam (140 keV median energy; average dose rate of 50 Gy/s) at the Australian Synchrotron. We
compare the results with those from similar cells treated using a conventional 150 kVp
orthovoltage field (dose rate of 0.0127 Gy/s). The results reveal that the high dose-rate
synchrotron irradiation is more effective at killing the 9L cells relative to the MDCK cells than
the orthovoltage irradiation. On the other hand, the NSPs are more effective at radiosensitizing
the 9L cells compared to the MDCK cells in the orthovoltage radiation field, which is due to the
NSP energy dependence in the kilovoltage energy range. Both the dose rate and energy spectrum
need to be considered in future studies with synchrotron activation radiotherapy (SART).

1. Introduction
High-Z nanoparticles (NPs) have been shown to improve the effectiveness of dose conformity to tumour
tissue, particularly with macroscopic (broad beam) kilovoltage x-rays [1, 2]. The advantages of NPs,
besides the primary benefit of enhancing local tumour radio-sensitivity, often include biocompatibility,
permeability to cell membranes due to their nano-scale dimensions, and engineered abilities to
specifically target certain tumours when coated.
Tantalum pentoxide (Ta2O5) nano-structured ceramic particles (TaNSPs) were first reported as
radio-sensitizers by Brown et al. 2014 [2]. Nano-structured ceramic particles (NSPs) have different
characteristics and furthermore, aggregation properties than inert metal NPs. TaNSPs have a high atomic
number (Z=73), are biocompatible, and its oxide component may provide a useful target for drug
attachment.
Polychromatic synchrotron radiation has significantly high dose rates, of order of tens to hundreds
of Gy per second. The effect of these beams on tumour tissue are not yet well documented, however it
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd
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is known that the inclusion of a high-Z targeting agents, such as platinum, gold, and iodine, can improve
the treatment efficiency of synchrotron treatments, in their lower dose-rate monochromatic mode [3].
We aim to provide preliminary evidence of increased tumour response to high dose rates when
compared to normal cells and characterise the ability of high-Z particles to selectively enhance
synchrotron therapies, determining their efficacy toward Synchrotron Activation Radiotherapy (SART).
2. Methods
Tantalum pentoxide NSPs were synthesized according to the method detailed by Brown et al. [2] with
sonication in an ultrasonic water bath, whilst suspended in PBS (phosphate buffered saline), for 2 hrs
and mixed at 30 min intervals to promote the formation of smaller aggregates.
The NSPs were added to T12.5cm2 cell culture flasks containing monolayers of 9L gliosarcoma
cancer cells (derived from rodent brain cells) or MDCK (Madin-Darby Canine Kidney) cells 24 hours
before 90-100% confluence. Each cell culture was grown with complete Dulbecco’s modified eagle
medium (c-DMEM) (DMEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and
streptomycin) and incubated at 37 °C and 5% (v/v) CO2. NSP concentrations ranging from 50-500
µg/mL were added into flasks containing 5 mL DMEM.
Following 24 hrs of incubation with the NSPs, the cells were subcultured into 100 mm diameter
petri dishes with 10 mL c-DMEM to evaluate NSP toxicity. Following 15 cell doubling times the cells
were washed with 5 mL PBS (with calcium and magnesium ions) and fixed and stained with 5 mL of a
(25% crystal violet and 75% ethanol) solution. Colonies consisting of no less than 50 cells were counted
as surviving. The plating efficiency was evaluated as the ratio between the number of colonies present
to the original cell seeding number. In this way, the impact of the irradiation or NSP toxicity was
evaluated by comparing the plating efficiency of these treatments directly to the control plating
efficiency and expressing this ratio as a normalized survival fraction.
For all experiments the flasks were irradiated when embedded in a 20 cm x 20 cm x 12 cm solid
water phantom (RMI-457) with the cells at 2.5 cm depth. The irradiation field size was large enough to
cover the whole flask in the case of the orthovoltage irradiations. For the synchrotron irradiations a step
and shoot technique was utilized to create the irradiation field from the 1 mm x 12 mm intrinsic radiation
field. The uniformity of the irradiation field was checked using EBT-3 film. The total dose was
confirmed via a PTW PinpointTM ion chamber (model 31014).
Flasks with or without 50 µg/mL of NSPs
were irradiated in a vertical orientation at
hutch 1B on the Imaging and Medical
Beamline (IMBL) at the Australian
Synchrotron, with a single dose (2 Gy), at 50
Gy/sec, using a pink beam (4.65 mm Cu ex
vacuo filtration). These results were
compared with 2 Gy low dose-rate (LDR) 150
kVp orthovoltage X-ray beam from a
Nucletron Oldelft Therapax DXT 300 Series
Figure 1.
Photon beam energy spectra of 150 kVp
3 Orthovoltage unit at 0.76 Gy/min.
orthovoltage X-rays (66 keV effective energy) and
The differences in energy spectra of these synchrotron pink beam (137 keV weighted average
beams is shown in Figure 1.
energy).

3. Results
Preliminary observations of TaNSPs with a light microscope, show they are distributed quite
homogeneously amongst MDCK flask, except for some aggregation outside the cells over time (Figure
2). However, the TaNSPs tend to form clusters around the cell nucleus in the 9L gliosarcoma cells
(Figure 3) due to the entrance of the TaNSPs into the cell and subsequent aggregation.
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Figure 2.
Ta2O5 NSPs
(black-brown) in MDCK.
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Figure 3. Ta2O5
(black) in 9L cells.

Toxicity of the Ta2O5 NSPs produce
population survivals of 80-100%, in both cell
lines without discrimination toward either cell
line, as shown in Figure 4 for a range of NP
concentrations.
In the case of 9L cells, the results are very
consistent with previously published data from a
different production batch and indicates the
excellent reproducibility of the production
technique.
This indicates that with TaNSPs, no toxic effect is
acting on either cell line, and the cell survival
following irradiation is purely dependent on the
efficacy of the treatment itself.

NSPs

Figure 4. Intrinsic toxicity of Ta2O5 NSPs for 9L and
MDCK cell lines.

Figure 5. 9L cell survival following orthovoltage or
synchrotron broad beam irradiation, with and without
NSPs.

Figure 6. MDCK cell survival following orthovoltage
or synchrotron broad beam irradiation, with and
without NSPs.

Figures 5 and 6 highlight the effects of the different dose-rates on the cancer and normal cell lines
respectively. Conventional 150 kVp orthovoltage treatment at 2 Gy LDR (low dose-rate) is compared
with a synchrotron HDR (high dose-rate) broad beam.
Radioresistant 9L gliosarcoma cells appear to be more affected by the high dose rate than the
MDCK cells. The orthovoltage treatment in comparison produces much greater 9L survival at 2 Gy than
the synchrotron radiation. Radiosensitive MDCK in contrast, shows that there is insignificant difference
between the orthovoltage treatment and HDR synchrotron treatment.
The addition of NSPs however, do not appear to significantly enhance the treatment of the 9L
cells using synchrotron radiation. In contrast, the orthovoltage treatment does see a noticeable dose
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enhancement expressed through an increase in cell death in the tumour cells. In the normal cells
however, there is no therapy enhancement in either LDR or HDR treatment. We believe this is due to
the difference in the nanoparticle uptake by the tumour line (more nanoparticles closer to the nucleus).
These results highlight the importance of considering the kV beam energy used for SART. NP
dose enhancement is indeed highly energy dependent in the kilovoltage range.
Figure 7 shows that the
150 kVp X-rays was precisely
chosen to more directly target the
photon absorption of the TaNPs
relative to water and therefore
optimize
cell
sensitization
enhancement. The broad beam
synchrotron radiation spectra
would need further optimization
and be lowered in energy to fully
take
advantage
of
dose
enhancement by photoelectric Figure 7. Comparison of beam energy spectra (grey) and ratio of total
effect on TaNSPs.
mass energy absorption coefficients of Ta2O5 to water (black) [4].

4. Conclusion
The inclusion of tantalum (V) oxide NSPs in kV beams is shown to improve tumour selectivity of the
therapy. We believe the improvement is related to the preferential uptake of the NSPs by the 9L
gliosarcoma cells compared to the MDCK kidney cells, which seems to naturally occur. The selective
uptake leads to a higher concentration of NSPs in the 9L cells compared to the MDCK cells. The higher
concentration also leads to selective dose enhancement in 9L cells due to the high-Z nature of the NSPs
acting to significantly increase the interaction cross section of the cells at low photon energies (40-100
keV). Furthermore, the high dose rate of the synchrotron broad beam tends to produce greater effect on
9L radioresistant tumorous cells. However, NSPs are less effective in the synchrotron broad field for
either cell line in this case, due to the beam energy spectrum requiring further optimization to maximize
the radiosensitization of the TaNSPs.
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